Obesity is one of the most significant public health challenges of the 21st century, with its prevalence continuously increasing worldwide. This condition is associated with an elevated risk of numerous metabolic, cardiovascular, and respiratory complications, leading to a substantial burden on healthcare systems. The pathophysiology of obesity is multifactorial and involves complex interactions between genetic, environmental, and neuroendocrine mechanisms regulating energy balance. Gastrointestinal hormones, including leptin, ghrelin, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP), play a crucial role in the regulation of appetite and metabolism. The aim of this study is to present current knowledge on the pathophysiology of obesity and to review contemporary and emerging treatment strategies. The article discusses classical therapeutic approaches, including lifestyle modification, dietary interventions, increased physical activity, and surgical treatment. Particular attention is given to modern pharmacological therapies targeting the incretin system. In recent years, significant progress has been made in the pharmacological treatment of obesity with the introduction of GLP-1 receptor agonists, such as semaglutide, as well as dual-acting agents, including tirzepatide, which acts as an agonist of both GLP-1 and GIP receptors. These therapies demonstrate high efficacy in body weight reduction by influencing central mechanisms of appetite regulation, delaying gastric emptying, and improving glucose metabolism. Furthermore, promising directions in obesity treatment are discussed, including triple incretin receptor agonists such as retatrutide, as well as combination therapies utilizing amylin analogues, for example CagriSema. In conclusion, the development of modern pharmacological therapies is significantly transforming the approach to obesity treatment and may in the future enable outcomes comparable to bariatric surgery. The integration of novel pharmacological methods with comprehensive lifestyle modification may represent the key to more effective management of obesity and reduction of its metabolic and cardiovascular complications.